Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb;15(2):128-134.
doi: 10.1002/alr.23459. Epub 2024 Sep 27.

The effect of allergen immunotherapy in patients with central compartment atopic disease post-surgery

Affiliations

The effect of allergen immunotherapy in patients with central compartment atopic disease post-surgery

Christian M Meerwein et al. Int Forum Allergy Rhinol. 2025 Feb.

Abstract

Objective: To assess the effect of allergen immunotherapy (AIT) on patients with central compartment atopic disease (CCAD) and house dust mite (HDM) sensitization post-surgery.

Methods: A retrospective cohort of surgically treated, HDM-sensitized CRSwNP patients phenotyped as CCAD was assessed. Patients were divided into two groups based on whether they had AIT commenced as part of their surgical care. All AIT patients started immunotherapy prior to their surgery. The primary endpoint was reformation of middle turbinate (MT) edema 12 months postsurgery. Secondary endpoints were corticosteroid irrigation use (<4 times/week vs. ≥4 times/week, %) and the rhinologic domain of the 22-item sino-nasal outcome test (SNOT-22). Demographic characteristics, concomitant asthma, smoking status, history of aspirin-exacerbated respiratory disease, conjunctival symptoms, polysensitization, serum eosinophils (cell × 109/L), tissue eosinophilia (% > 100/HPF), and serum IgE (kU/L) were also recorded.

Results: Eighty-six CCAD patients were assessed (41 ± 14 yrs, 64% female). AIT was applied in 37% (n = 32). Baseline features were similar apart from greater conjunctival symptoms (72 vs. 45%, p = 0.02) in the AIT group. At 12 months post-surgery, the AIT group has less MT edema (% ≥ diffuse 15.6 vs. 52.9, p < 0.01). Patients on AIT also had less pharmacotherapy requirements at 12 months (% ≥ 4/week, 37.5 vs. 79.6%, p < 0.01). The rhinologic symptoms were similar (21.1 ± 17.1 vs. 20.1 ± 21.6, p = 0.83).

Conclusions: Surgery and pharmacotherapy are effective in managing CCAD, but the addition of AIT improved allergic phenomenon and allowed de-escalation of topical therapy. Longer term studies are required to demonstrate further immunomodulation.

Keywords: desensitization; hypersensitivity; immunologic; nasal surgical procedures; sinusitis.

PubMed Disclaimer

Conflict of interest statement

Richard J. Harvey is consultant/advisory board with Medtronic, Novartis, Glaxo‐Smith‐Kline, and Meda Pharmaceuticals. He has been on the speakers’ bureau for Glaxo‐Smith‐Kline, Astra‐Zeneca, Meda Pharmaceuticals, and Seqirus. Larry Kalish is on the speakers’ bureau for Viatris, Stallergenens, and Seqirus Pharmaceuticals. Raewyn G. Campbell is on the speaker's bureau for Medtronic, Viatris, and Glaxo‐Smith‐Kline. All other authors have no personal, financial, or institutional interest in any drugs, materials, or devices described in this article.

Figures

FIGURE 1
FIGURE 1
Examples of patients with normal configuration of the MT (A), focal edema (white arrowhead) (B), multifocal edema (white arrowheads) (C), diffuse edema (white arrowhead) (D) and polypoid edema with extension towards the nasal septum (white arrowheads) (E) at the 12 month assessment post‐surgery. MT, middle turbinate.

References

    1. Steehler AJ, Vuncannon JR, Wise SK, DelGaudio JM. Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2021;11(11). doi:10.1002/alr.22819 - DOI - PubMed
    1. Sit A, Alvarado R, Earls P, et al. CCAD or eCRS: defining eosinophilic subpopulations in chronic rhinosinusitis. Am J Rhinol Allergy. 2023;37(4). doi:10.1177/19458924231155012 - DOI - PMC - PubMed
    1. Grayson JW, Cavada M, Harvey RJ. Clinically relevant phenotypes in chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2019;48(1). doi:10.1186/s40463-019-0350-y - DOI - PMC - PubMed
    1. DelGaudio JM, Loftus PA, Hamizan AW, Harvey RJ, Wise SK. Central compartment atopic disease. Am J Rhinol Allergy. 2017;31(4). doi:10.2500/ajra.2017.31.4443 - DOI - PubMed
    1. Tripathi SH, Ungerer HN, Rullan‐Oliver B, et al. Similarities between allergen sensitivity patterns of central compartment atopic disease and allergic rhinitis. Int Forum Allergy Rhinol. 2022;12(10). doi:10.1002/alr.22983 - DOI - PubMed